We are live on ! Find out more
AXDX

Accelerate Diagnostics
AXDX

Delisted

AXDX was delisted on the 14th of May, 2025.

Back to rankings

123 hedge funds and large institutions have $448M invested in Accelerate Diagnostics in 2020 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 44 increasing their positions, 21 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

156% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 9

110% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 21

82% more capital invested

Capital invested by funds: $246M → $448M (+$202M)

12% more funds holding

Funds holding: 110 → 123 (+13)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

34% less call options, than puts

Call options by funds: $5.31M | Put options by funds: $8.09M

Holders
123
Holders Change
+13
Holders Change %
+11.82%
% of All Funds
2.52%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
23
Increased
44
Reduced
21
Closed
9
Calls
$5.31M
Puts
$8.09M
Net Calls
-$2.78M
Net Calls Change
-$1.14M

Top Buyers

Rank Fund Capital Flow
1
Baird Financial Group
Baird Financial Group
Wisconsin
+$4.18M
2
Morgan Stanley
Morgan Stanley
New York
+$4.18M
3
SM
Senvest Management
New York
+$2.6M
4
BlackRock
BlackRock
New York
+$1.58M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$1.46M

Top Sellers

Rank Fund Capital Flow
1
CS
Credit Suisse
Switzerland
-$11.9M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$2.57M
3
JMPWA
JP Morgan Private Wealth Advisors
California
-$1.97M
4
Citadel Advisors
Citadel Advisors
Florida
-$1.82M
5
CC
Chicago Capital
Illinois
-$1.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
N
26
Nuveen
North Carolina
$3.08M -$807K -8,189 -29%
Royal Bank of Canada
27
Royal Bank of Canada
Ontario, Canada
$3.05M +$1.19M +12,020 +148%
Charles Schwab
28
Charles Schwab
California
$2.82M +$188K +1,905 +11%
BAMCO Inc
29
BAMCO Inc
New York
$2.5M – – –
BNP Paribas Financial Markets
30
BNP Paribas Financial Markets
France
$2.4M -$266K -2,701 -15%
OCMI
31
Oaktop Capital Management II
New Jersey
$2.35M – – –
Bank of New York Mellon
32
Bank of New York Mellon
New York
$2.01M +$114K +1,156 +10%
PFM
33
Premier Fund Managers
United Kingdom
$1.85M +$1.2M +12,190 New
Marshall Wace
34
Marshall Wace
United Kingdom
$1.69M +$752K +7,624 +215%
Arrowstreet Capital
35
Arrowstreet Capital
Massachusetts
$1.6M +$1.04M +10,540 New
Two Sigma Advisers
36
Two Sigma Advisers
New York
$1.52M +$482K +4,890 +95%
D.E. Shaw & Co
37
D.E. Shaw & Co
New York
$1.51M +$353K +3,579 +56%
Goldman Sachs
38
Goldman Sachs
New York
$1.4M +$64.6K +655 +8%
UBS Group
39
UBS Group
Switzerland
$1.29M -$1.15M -11,620 -58%
Swiss National Bank
40
Swiss National Bank
Switzerland
$1.04M +$102K +1,030 +18%
Barclays
41
Barclays
United Kingdom
$1.01M +$356K +3,615 +119%
California Public Employees Retirement System
42
California Public Employees Retirement System
California
$935K +$9.56K +97 +2%
TWA
43
TCI Wealth Advisors
Arizona
$843K – – –
AllianceBernstein
44
AllianceBernstein
Tennessee
$807K +$61.1K +620 +13%
TIM
45
Thompson Investment Management
Wisconsin
$802K – – –
MWNA
46
Marshall Wace North America
New York
$799K +$397K +4,030 +326%
TMC
47
Trellus Management Company
Florida
$758K +$271K +2,750 +122%
AIM
48
Aigen Investment Management
New York
$705K +$315K +3,195 +219%
California State Teachers Retirement System (CalSTRS)
49
California State Teachers Retirement System (CalSTRS)
California
$697K +$37.9K +384 +9%
Wells Fargo
50
Wells Fargo
California
$672K +$249K +2,522 +132%
1
2
3 4 5

AXDX Hedge Fund Activity: Q2 2020 in Review

123 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Accelerate Diagnostics (AXDX) for Q2 2020, worth a combined $448M — up 82% from $246M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new AXDX positions and 9 closed out — a net gain of 14 holders — while 44 added to existing stakes and 21 trimmed.

The largest buyer was Baird Financial Group, adding an estimated $4.18M. The largest seller was Credit Suisse, cutting an estimated $11.9M.

  • 123 institutional investors held Accelerate Diagnostics (AXDX) as of Q2 2020, up from 110 in Q1 2020.
  • Funds reported $448M of Accelerate Diagnostics stock for Q2 2020, up 82% quarter-over-quarter.
  • 23 funds opened new Accelerate Diagnostics positions in Q2 2020 and 9 closed out, a net change of +14 holders.
  • The largest Accelerate Diagnostics buyer in Q2 2020 was Baird Financial Group, an estimated $4.18M added.
  • The largest Accelerate Diagnostics seller in Q2 2020 was Credit Suisse, an estimated $11.9M sold.

Based on aggregated 13F filings for Q2 2020.